Page last updated: 2024-11-07

methylprednisolone acetate and Bone Diseases, Metabolic

methylprednisolone acetate has been researched along with Bone Diseases, Metabolic in 5 studies

Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.

Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.

Research Excerpts

ExcerptRelevanceReference
" 2) Eight week treatment with the selected dosing regimen (n = 6) of the steroid and histomorphometry including strut analysis measured the development of a characteristic osteopenia which can be described briefly as "uncut but thinning" of trabecular bone structure, and which was prevented by salmon calcitonin (0."1.29Glucocorticoid-induced osteopenia in rats: histomorphometrical and microarchitectural characterization and calcitonin effect. ( Hoshino, T; Koida, M; Nakamuta, H; Nitta, T, 1996)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mahl, CR1
Fontanella, V1
Takahashi, K1
Fukushima, S1
Nozaki, K1
Kokubo, S1
Teramura, K1
Miyata, K1
Nakamuta, H3
Nitta, T2
Hoshino, T1
Koida, M3
Fukushima, T1
Furuichi, H1
Fukuyama, R1
Izumo, N1
Fujita, T1
Kohno, T1

Other Studies

5 other studies available for methylprednisolone acetate and Bone Diseases, Metabolic

ArticleYear
Evaluation by digital subtraction radiography of induced changes in the bone density of the female rat mandible.
    Dento maxillo facial radiology, 2008, Volume: 37, Issue:8

    Topics: Animals; Anti-Inflammatory Agents; Bone Density; Bone Density Conservation Agents; Bone Diseases, Me

2008
Effect of incadronate on corticosteroid-induced osteopenia in rats.
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2004, Volume: 124, Issue:9

    Topics: Administration, Oral; Animals; Bone Density; Bone Diseases, Metabolic; Compressive Strength; Diphosp

2004
Glucocorticoid-induced osteopenia in rats: histomorphometrical and microarchitectural characterization and calcitonin effect.
    Biological & pharmaceutical bulletin, 1996, Volume: 19, Issue:2

    Topics: Animals; Bone Diseases, Metabolic; Calcitonin; Male; Methylprednisolone; Methylprednisolone Acetate;

1996
Glucocorticoid-induced secondary osteopenia in female rats: a time course study as compared with ovariectomy-induced osteopenia and response to salmon calcitonin.
    Japanese journal of pharmacology, 1999, Volume: 79, Issue:3

    Topics: Analgesics; Animals; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Bone Resorption; Calci

1999
Bone-anabolic effect of salmon calcitonin on glucocorticoid-induced osteopenia in rats.
    Biological & pharmaceutical bulletin, 2000, Volume: 23, Issue:8

    Topics: Animals; Bone Development; Bone Diseases, Metabolic; Calcitonin; Female; Male; Methylprednisolone; M

2000